CD8A and breast cancer: In murine breast cancer models, depletion of Tregs using anti-CD25 antibodies or genetic ablation (FoxP3-Diphtheria Toxin system) enhances CD8+ T cell infiltration and delays tumor progression, confirming their direct role in suppressing anti-tumor immunity [178].